# Locomotion and end-effector pose tracking on Simulation Environment Complete Weakening k\_tau=0.0

Source: [Locomotion and end-effector pose tracking on Simulation Environment Complete Weakening k\_tau=0.0](<https://www.sota2.com/research/sota/locomotion-and-end-effector-pose-tracking-on-simulation-environment-complete-weakening-k_tau-0-0>)

Collection index: [llms.txt](<https://www.sota2.com/research/llms.txt>)

Data updated: 2026-06-24T08:29:43.206Z

Evaluation of combined locomotion and end-effector pose tracking performance within the 'Simulation Environment Complete Weakening' setup, specifically for the k\_tau=0.0 condition, measured by survival rate and workspace volume.

A research result applies to its stated dataset, split, metric and evaluation configuration. Compare like-for-like settings, preserve the metric's unit and direction, and distinguish paper-reported results from independent reproduction. The best result recorded here is not a claim of exhaustive, current global coverage.

| Scope | Recorded value |
| --- | --- |
| Task | Locomotion and end-effector pose tracking |
| Dataset (including any stated split) | Simulation Environment Complete Weakening k\_tau=0.0 |
| Metric | Survival Rate |
| Unit | PERCENT |
| Direction | Higher is better |
| Results loaded | 26 of 26 |
| Coverage | All results currently returned for this benchmark |

Evaluation settings may differ between results. The original papers and recorded configurations are needed to establish comparability. A shared metric name alone does not establish an identical protocol.

## Metrics

- [Survival Rate](<https://www.sota2.com/research/sota/locomotion-and-end-effector-pose-tracking-on-simulation-environment-complete-weakening-k_tau-0-0.md?metric=Survival%20Rate>): Higher is better; unit: PERCENT.

- [Workspace (m^3)](<https://www.sota2.com/research/sota/locomotion-and-end-effector-pose-tracking-on-simulation-environment-complete-weakening-k_tau-0-0.md?metric=Workspace%20(m%5E3)>): Higher is better; unit: SIZE.

## Recorded results

| Method | Survival Rate | Result date | Report paper |
| --- | --- | --- | --- |
| FT-WBC | 89.8 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 88.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 86.5 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 84.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 83.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 80.8 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 80.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 76.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 73.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 70.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 68.8 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 67.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 66.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 62.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 58.7 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 55.6 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 55.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 53.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 52.5 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 50.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 45.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 42.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 39.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 37.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 35.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 29.4 | Not recorded | 6a3b64d5206542251d7c98ff |

### FT-WBC

Survival Rate: 89.8. Result ID: 6a3b956dfbc373592c4499d5.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 88.1. Result ID: 6a3b956dfbc373592c4499d1.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 86.5. Result ID: 6a3b956dfbc373592c4499cd.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 84.3. Result ID: 6a3b956dfbc373592c4499c9.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 83.4. Result ID: 6a3b956dfbc373592c4499d4.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 80.8. Result ID: 6a3b956dfbc373592c4499d9.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 80.2. Result ID: 6a3b956dfbc373592c4499d0.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 76.3. Result ID: 6a3b956dfbc373592c4499cc.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 73.1. Result ID: 6a3b956dfbc373592c4499c8.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 70.3. Result ID: 6a3b956dfbc373592c4499d8.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 68.8. Result ID: 6a3b956dfbc373592c4499c5.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Calf"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 67.2. Result ID: 6a3b956dfbc373592c4499c2.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Calf"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 66.3. Result ID: 6a3b956dfbc373592c4499d3.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 62.4. Result ID: 6a3b956dfbc373592c4499cf.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 58.7. Result ID: 6a3b956dfbc373592c4499cb.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 55.6. Result ID: 6a3b956dfbc373592c4499c4.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Calf"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 55.2. Result ID: 6a3b956dfbc373592c4499c7.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 53.4. Result ID: 6a3b956dfbc373592c4499c1.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Calf"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 52.5. Result ID: 6a3b956dfbc373592c4499d7.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 50.2. Result ID: 6a3b956dfbc373592c4499d2.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 45.3. Result ID: 6a3b956dfbc373592c4499ce.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 42.1. Result ID: 6a3b956dfbc373592c4499ca.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 39.4. Result ID: 6a3b956dfbc373592c4499c6.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 37.4. Result ID: 6a3b956dfbc373592c4499c3.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Calf"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 35.1. Result ID: 6a3b956dfbc373592c4499c0.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Calf"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 29.4. Result ID: 6a3b956dfbc373592c4499d6.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

Page 1 of 1. This is an index page, not the full collection.
